Exagen, Inc. (XGN)

7.03 +0.06 (+0.86%) USD  |  NASDAQ  |  Sep 11, 16:00
7.03 0.00 (0.00%) After-Hours: 17:27
More

Exagen Gross Profit (TTM) : 41.70M for June 30, 2026

Gross Profit (TTM) Chart

View Gross Profit (TTM) for XGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (TTM) Chart
Start Trial

Historical Gross Profit (TTM) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 41.70M
March 31, 2026 39.88M
December 31, 2025 38.80M
September 30, 2025 38.07M
June 30, 2025 34.98M
March 31, 2025 33.64M
December 31, 2024 33.11M
September 30, 2024 32.78M
June 30, 2024 33.50M
March 31, 2024 32.75M
December 31, 2023 29.46M
September 30, 2023 27.84M
June 30, 2023 28.85M
March 31, 2023 22.08M
December 31, 2022 21.35M
September 30, 2022 22.57M
June 30, 2022 20.62M
March 31, 2022 26.41M
December 31, 2021 27.71M
September 30, 2021 28.29M
June 30, 2021 27.96M
March 31, 2021 26.25M
December 31, 2020 25.42M
Date Value
September 30, 2020 22.71M
June 30, 2020 21.93M
March 31, 2020 21.80M
December 31, 2019 21.58M
September 30, 2019 21.59M
June 30, 2019 20.26M
March 31, 2019 18.64M
December 31, 2018 16.92M
September 30, 2018 13.18M
June 30, 2018 10.97M
March 31, 2018 9.10M
December 31, 2015 8.205M
September 30, 2015 8.324M
June 30, 2015 7.823M
March 31, 2015 6.604M
December 31, 2014 4.558M
September 30, 2014 2.702M
June 30, 2014 1.223M
March 31, 2014 0.373M
December 31, 2013 0.011M
September 30, 2013 -0.148M
June 30, 2013 -0.284M
March 31, 2013 -0.208M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Myriad Genetics, Inc. 525.10M
BioRestorative Therapies, Inc. 0.119M
CareDx, Inc. 321.18M
Natera, Inc. 1.753B
Sera Prognostics, Inc. -0.86M